Moderna, Inc. (MRNA)
NGS · Common · CUSIP 60770K107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for MRNA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
60770K107
Market Cap
Large Cap · $22 Billion
IPO
12/6/2018 · $23.00/share
Business: Moderna, Inc. pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines to direct the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals.

Company Contact

CEO
Stéphane Bancel
CFO
David Meline
Headquarters
200 Technology Square, Cambridge, MA 02139
Phone
617-714-6500
Investor Relations
Lavina Talukdar · 617-209-5834 · Lavina.Talukdar@modernatx.com
General Email
IR@modernatx.com
SEC EDGAR Filings
View filings »